methoxy-morpholinyl-doxorubicin and Experimental Neoplasms

methoxy-morpholinyl-doxorubicin has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Floreani, M; Geroni, C; Napoli, E; Quintieri, L; Rosato, A; Sola, F; Zanovello, P	1
Bargiotti, A; Farao, M; Grandi, M; Pastori, A; Pesenti, E; Pezzoni, G; Ripamonti, M; Spreafico, F; Suarato, A	1
Ballinari, D; Capolongo, L; Grandi, M; Pastori, A; Ripamonti, M; Spreafico, F; Suarato, A	1

Reviews

1 review(s) available for methoxy-morpholinyl-doxorubicin and Experimental Neoplasms

Article	Year
[New anthracyclines and multidrug resistance]. Haematologica, 1991, Volume: 76 Suppl 3 Topics: Animals; Breast Neoplasms; Doxorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia; Leukemia L1210; Mice; Neoplasms, Experimental; Structure-Activity Relationship; Tumor Cells, Cultured	1991

Other Studies

2 other study(ies) available for methoxy-morpholinyl-doxorubicin and Experimental Neoplasms

Article	Year
In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A. Cancer research, 2000, Jun-15, Volume: 60, Issue:12 Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Bone Marrow; Coculture Techniques; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Doxorubicin; Erythromycin; Female; Leukemia, Experimental; Liver; Liver Neoplasms, Experimental; Methylation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microsomes, Liver; NADP; Neoplasm Transplantation; Neoplasms, Experimental; Oxidoreductases, N-Demethylating; Pregnenolone Carbonitrile; Protein Synthesis Inhibitors; Time Factors; Troleandomycin; Tumor Cells, Cultured	2000
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells. British journal of cancer, 1992, Volume: 65, Issue:5 Topics: Animals; Doxorubicin; Female; Humans; Leukemia P388; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous; Tumor Cells, Cultured	1992

Article

Year

In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.

Cancer research, 2000, Jun-15, Volume: 60, Issue:12

Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Bone Marrow; Coculture Techniques; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Doxorubicin; Erythromycin; Female; Leukemia, Experimental; Liver; Liver Neoplasms, Experimental; Methylation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microsomes, Liver; NADP; Neoplasm Transplantation; Neoplasms, Experimental; Oxidoreductases, N-Demethylating; Pregnenolone Carbonitrile; Protein Synthesis Inhibitors; Time Factors; Troleandomycin; Tumor Cells, Cultured

2000

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.

British journal of cancer, 1992, Volume: 65, Issue:5

Topics: Animals; Doxorubicin; Female; Humans; Leukemia P388; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous; Tumor Cells, Cultured

1992